Purpose of the development: High-performance antivirus and immunomodulatory drugs VIREKSY type I interferons are intended for use as an effective means to improve the immunobiological reactivity of the animal organism.

Recommended application field: Agriculture. Livestock.

Advantages over analogues: Vireksy cause a sharp increase in the body's resistance to infectious agents or their removal, promote the rapid achievement of clinical effect in patients with animals.

The development stage readiness: Ready for application

Description of the development:
()
Group of modern immunomodulators Vireksov prepared using unconventional materials , species-specific effect of these drugs . Vireksy - Porkavireks ( pigs) Bovivireks ( cattle) , Kanivireks ( dogs , foxes, foxes ) - non-toxic , not antigens homologous animals are harmless , do not cause side effects , especially allergic reactions. Preparations of this type increase the level of innate immunity not only viral but also bacterial infections , especially in the early stages of the process , particularly in young animals. Vireksy have pronounced immunomodulatory properties with the activation of phagocytic cells . This is particularly important for the prevention and treatment of infectious diseases in newborn animals whose immune system is not yet formed . Patent of Ukraine . Specifications.

Information about newness of the development:
there are Ukrainian patents -- 1 items

corresponds technical description
Guarantees stable results getting

Possibility of transfer abroad:
Licence's sale
Licence's sale
Technological document's sale
Creation of joint enterprise
Realization of finished commodity

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua